Drug candidate selected for ABS-201, a novel, potentially category-defining anti-PRLR antibody in development for androgenic alopecia
Leading AI platform demonstrated breakthrough in successful de novo design of antibody targeting previously difficult-to-drug epitope in the HIV “caldera” region
Read more at globenewswire.comABSCI CORP
NASDAQ:ABSI (2/11/2025, 3:28:08 PM)
4.745
+0.42 (+9.58%)
20 days ago - ChartmillCurious about what's happening in today's session? Check out the latest stock movements and price changes.Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
20 days ago - ChartmillGapping stocks in Wednesday's sessionLet's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
